A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

Clinical trial NCT07500207 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07500207
Sponsor: Changchun BCHT Biotechnology Co.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Rabies Prevention

Start date: 2026-03-04
Primary completion: 2026-05-25
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.